Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Dipyridamole modified release

Brand: 
NICE TA: 210
Indication: Prevention of occlusive vascular events (NICE TA210)
Disease category: Cardiovascular system
Commissioning responsibility: CCG
PbR excluded: No

Background

Recommendation

LMMG recommendation: Green
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for initiation in primary care

Supporting documents:

NICE TA210 - Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Green

Green

Green

Green

Green